RESIDUAL DISEASE AND RELAPSE: HOW STOCHASTIC FOUNDER EFFECTS SHAPE PEDIATRIC ALL OUTCOMES

EHA Library, Virginia Turati, 4160407

MAPPING THE AKR1C3 CIS-REGULOME IN ACUTE LYMPHOBLASTIC LEUKEMIA TO ENHANCE TARGETED THERAPY WITH A NEW AKR1C3-ACTIVATED PRODRUG

EHA Library, Hansen Kosasih, 4160408

AGE-DEPENDENT TUMOUR-IMMUNE INTERACTIONS GOVERNS IMMUNOTHERAPY RESPONSES IN LEUKAEMIA AND OTHER PAEDIATRIC CANCERS

EHA Library, Sebastien Malinge, 4160409

EPIGENETIC DETERMINANTS CONFERRING GLUCOCORTICOID RESISTANCE IN PAEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Yashna Walia, 4160410

DIGITAL DROPLET PCR FOR MINIMAL RESIDUAL DISEASE MONITORING IN PHILADELPHIA NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A REPORT FROM THE PROSPECTIVE NORTHERN ITALY LEUKEMIA GROUP (NILG) ALL 10/07 STUDY

EHA Library, Francesco Ballardini, 4160411

DISCOVERY OF A NOVEL BCP-ALL MOLECULAR SUBGROUP DEFINED BY IGH::FENDRR GENE FUSION, FOXF1 OVEREXPRESSION AND KRAS A146 MUTATION

EHA Library, Sonja Bendig, 4160412

CREB-BINDING PROTEIN (CBP) DEFICIENCY IN THE EARLY B CELL COMPARTMENT IMPAIRS IMMUNE RESPONSES AND ALTERS GUT MICROBIOME DYNAMICS DURING CHRONIC VIRAL INFECTION

EHA Library, Zhe Lu, 4160414

DRUG-RESPONSE MODULATING GENES IN ETV6::RUNX1 CHILDHOOD LEUKEMIA

EHA Library, Laura Oksa, 4160415

EFFICACY OF NOVEL TARGETED THERAPIES IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Kunjal Panchal, 4160417

TARGETING POLYAMINES IN PEDIATRIC TCF3::PBX1 B-ALL

EHA Library, James Kim, 4160418

ANTIBIOTIC-RELATED MICROBIOME DYSBIOSIS DAMPENS HEMATOLOGIC RECOVERY AFTER CD19 CAR-T CELL INFUSION

EHA Library, Jiachen Liu, 4160419

DEEP MOLECULAR PROFILING REVEALS PROGNOSTIC MARKERS FOR REFINED PATIENT STRATIFICATION AND TARGETABLE ALTERATIONS IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Borbála Péterffy, 4160420

SENSITISATION AND ERADICATION OF DRUG-RESISTANT PAEDIATRIC ETP-ALL BY REPURPOSING DECITABINE

EHA Library, Yizhou Huang, 4160422

ROLE OF TP53 MUTATIONS IN REFINING PROGNOSIS OF KTM2A-REARRANGED ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS

EHA Library, Mariangela Di Trani, 4160425

NOTCH1 TRANSLOCATIONS DEFINE A SPECIFIC SUBTYPE OF HIGH-RISK CORTICAL TYPE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Martina Lucarelli, 4160426

BCR::ABL1 BALANCES CELLULAR DEMAND AND SUPPLY BY JOINTLY ENGAGING STAT5 SIGNALING AND GLYCOLYTIC METABOLISM DOWNSTREAM OF INTERLEUKIN 7 RECEPTOR IN MURINE PREB CELLS

EHA Library, Dennis Das Gupta, 4160429

TARGETING ONCOGENE-INDUCED SENESCENCE IN ETV6::RUNX1 PRE-LEUKEMIC CELLS

EHA Library, Mayla Bertagna, 4160430

INDUCTION OF ONTOGENY-SPECIFIC PRE-LEUKEMIC STEM CELLS IN A KMT2A::AFF1 MURINE MODEL

EHA Library, Ariana Calderón, 4160431

THERAPEUTIC EFFICACY OF BIOMIMETIC NANODRUG CX4945 IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Yan Wang, 4160432

CHEMORESISTANT ALL CELL LINES EXHIBIT REDUCED MITOCHONDRIAL DAMAGE AND INCREASED MITOCHONDRIAL BIOGENESIS UPON CHEMOTHERAPY.

EHA Library, Jenny Chatzigerou, 4160434

MOLECULAR DETERMINANTS OF SENSITIVITY AND RESISTANCE TO A NOVEL AKR1C3-ACTIVATED PRODRUG IN PEDIATRIC LEUKEMIA

EHA Library, Faezeh Khalili, 4160436

THE EXPRESSION AND FUNCTION OF NINJURIN2 IN ACUTE T-LYMPHOID LEUKEMIA

EHA Library, Hongxia Chen, 4160437

WHOLE TRANSCRIPTOME SEQUENCING UNCOVERS KEY CODING AND NON-CODING BIOMARKERS IN IKZF1PLUS B-ALL

EHA Library, Gadha Krishna Leons, 4160438

IDENTIFYING SYNERGISTIC ACTIVITIES OF COMBINED INHIBITION OF TYROSINE KINASES AND ANTI-APOPTOTIC MOLECULES IN ABL1 FUSION-POSITIVE ALL

EHA Library, Johanna Bender, 4160439

ROLE OF FRUCTOSE TRANSPORTER (GLUT5) EXPRESSION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Serene Xavier, 4160440

LONG NON-CODING RNAS AND THEIR ROLE ON EPIGENOME AS DIAGNOSTIC MARKERS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA OF T CELLS

EHA Library, Giovanni Smaldone, 4160441

B-PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA CAUSES PARACRINE SENESCENCE IN MESENCHYMAL STROMAL CELLS TO SUBVERT THE TREATMENT RESPONSE IN ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA

EHA Library, Aditi Dey, 4160442

LONG-TERM OUTCOMES OF PEBL-ENGINEERED CD7 NANOBODY CAR-T (PA3-17 INJECTION) IN RELAPSED/REFRACTORY T-ALL/LBL: PHASE I TRIAL UPDATE

EHA Library, Meng Lv, 4160445

INOTUZUMAB OZOGAMICIN IN PEDIATRIC CD22-POSITIVE VERY HIGH RISK FIRST RELAPSE B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA: PRELIMINARY RESULTS OF THE ITCC-059 STUDY

EHA Library, Erica Brivio, 4160447

COMBINATION OF OLVEREMBATINIB AND VP REGIMEN AS FIRST-LINE THERAPY FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A SINGLE-ARM, MULTICENTRE, PHASE 2 TRIAL

EHA Library, Gaixiang Xu, 4160448

MUTATIONS IN GENES ASSOCIATED WITH CLONAL HEMATOPOIESIS IN PATIENTS WITH ACUTE T-CELL LYMPHOBLASTIC LEUKEMIA/LYMPHOMA

EHA Library, Anastasia Vasilieva, 4160449

HIGH IL7R DEFINES FAVORABLE T-ALL PROGNOSIS: CROSS-VALIDATION IN PEDIATRIC COHORTS

EHA Library, Senlin Zhang, 4160450

CLINICAL EFFICACY ANALYSIS OF CAR-T THERAPY IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH EXTRAMEDULLARY DISEASE

EHA Library, Zhao defeng, 4160454

COMPARATIVE EFFICACY OF THE GIMEMA LAL1913 STANDARD CHEMOTHERAPY PROTOCOL VERSUS THE STANDARD ARM OF THE E1910 TRIAL IN MRD-NEGATIVE PH-NEGATIVE ALL: A MAIC ANALYSIS

EHA Library, Alfonso Piciocchi, 4160455

PROGNOSTIC SCORE MODELING FOR ADULT PATIENTS WITH PHILADELPHIA CHROMOSSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, Eduardo Chapchap, 4160456

RELAPSE RISK AND OUTCOME OF DISCONTINUING ASPARAGINASE IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

EHA Library, xingchen wang, 4160457

T-ACUTE LYMPHOCYTIC LEUKEMIA: NEW PERSPECTIVES ON DIFFERENCES IN IMMUNOPHENOTYPES AND GENE PROFILES BETWEEN CHILDREN AND ADULTS

EHA Library, Siyu Liu, 4160459

DEFIBROTIDE TREATMENT OUTCOMES IN PATIENTS WITH VENO-OCCLUSIVE DISEASE/SINUSOIDAL OBSTRUCTION SYNDROME (VOD/SOS) OCCURRING AFTER EXPOSURE TO INOTUZUMAB (INO) OR GEMTUZUMAB (GO)

EHA Library, Mohamad Mohty, 4160460

VENETOCLAX, TUCIDINOSTAT, PEGASPARGASE, AND DEXAMETHASONE INDUCTION REGIMEN FOR NEWLY DIAGNOSED ADULT ETP-ALL: A CHEMOTHERAPY-FREE, LOW-TOXICITY, EFFECTIVE REGIMEN

EHA Library, Jieping Lin, 4160462

EFFICACY AND SAFETY OF THE THIRD-GENERATION TYROSINE KINASE INHIBITOR OLVEREMBATINIB IN COMBINATION WITH INOTUZUMAB OZOGAMICIN FOR THE TREATMENT OF ADULT PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA PATIENTS WITH RELAPSED DISEASE OR PERSISTENT MINIMAL RESIDUAL DISEASE BRIDGING TO HEMATOPOIETIC STEM CELL TRANSPLANTATION: A PHASE II STUDY

EHA Library, Xiaoyu Zhang, 4160463

GENETIC CHARACTERISTICS OF BCR::ABL1-POSITIVE B-ACUTE LYMPHOBLASTIC LEUKEMIA WITH MULTILINEAGE INVOLVEMENT AND POST-HSCT SURVIVAL ANALYSIS

EHA Library, Tong Wang, 4160464

MRD-BASED TARGET THERAPY FOR PH-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULT PATIENTS BY THE RALL-2016M PROTOCOL: EFFECTIVE FOR BCP-ALL, SHOWS NO EFFICACY IN T-ALL

EHA Library, Olga Aleshina Gavrilina, 4160465

REAL-WORLD OUTCOMES OF PHILADELPHIA CHROMOSOME-NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN ADULTS TREATED WITH A PEDIATRIC-INSPIRED PROTOCOL: A COMPARISON ACROSS TWO TIME PERIODS

EHA Library, Maria Agustina Perusini, 4160468

NOVEL EUROFLOW QUALITY ASSESSMENT ON B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA MINIMAL RESIDUAL DISEASE. PROGRAM DEVELOPMENT AND FOUR ROUNDS OF IMPLEMENTATION

EHA Library, Michaela Reiterová, 4160471

CO-OCCURRENCE OF CHILDHOOD ACUTE LEUKEMIA AND TYPE 1 DIABETES MELLITUS: A FINNISH CASE-CONTROL STUDY

EHA Library, Julia Ventelä, 4160473

TARGETING MUTANT TP53 ACUTE MYELOID LEUKEMIA THROUGH DISRUPTION OF MYC-GSPT1 AXIS

EHA Library, Michael Andreeff, 4160474

TARGETING O-GLCNAC TRANSFERASE (OGT)-MEDIATED DRUG RESISTANCE IN INV(3)/T(3;3) AML

EHA Library, Junbum Im, 4160476

TBK1-OPTN INTERACTION PROMOTES AML PROLIFERATION AND VENETOCLAX RESISTANCE BY ACTIVATING MITOPHAGY, TARGETED BY A NOVEL INHIBITOR PEPTIDE

EHA Library, Fan Niu, 4160478

GATA2 N-TERMINAL ZINC FINGER DOMAIN MUTATIONS PROMOTE ERYTHROID CLONAL EXPANSION IN ACUTE MYELOID LEUKEMIA

EHA Library, Tianhui Liu, 4160479

MAPPING LEUKEMIC STEM CELLS IN PEDIATRIC AML: A MULTIMODAL FRAMEWORK TO PRECISION TARGETING

EHA Library, sina kanannejad, 4160480

SINGLE-CELL DISSECTION OF SELF-DERIVED VERSUS DONOR-DERIVED T-CELL EXHAUSTION IN BONE MARROW NICHES OF PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Chunzi Yu, 4160481

MITOLEUK SCORE: MITOCHONDRIAL GENOME VARIANTS AS A PROGNOSTIC CLASSIFIER FOR ACUTE MYELOID LEUKEMIA COMPLEMENTARY TO EUROPEAN LEUKEMIANET CLASSIFICATION

EHA Library, Julie Mondet, 4160483

SINGLE-CELL PROFILING IDENTIFIES LEUKEMIC STEM CELL SUBTYPES LINKED TO ATRA SENSITIVITY IN RAS MUTANT ACUTE MYELOID LEUKEMIA

EHA Library, Diego A Pereira-Martins, 4160484

PEDIATRIC AML BLASTS PROMOTE AN IMMUNOSUPPRESSIVE M2-LIKE PHENOTYPE BY REPROGRAMMING MACROPHAGE METABOLISM.

EHA Library, Alicia Perzolli, 4160485

MICROBIOTA-INSPIRED COMPOUNDS AS NOVEL DRUG CANDIDATES TARGETING NPM1-MUTATED ACUTE MYELOID LEUKEMIA

EHA Library, Miguel Ángel Navarro Aguadero, 4160486

DEEP IMMUNOPHENOTYPING BY MASS CYTOMETRY ELUCIDATES THE PROGENITOR TRAJECTORY OF ERYTHROID-DERIVED ACUTE MYELOID LEUKEMIA

EHA Library, Inga KF Motzfeldt, 4160487

SYNERGISTIC EFFECTS OF PRL2 AND TKI CO-INHIBITION IN FLT3-MUTATED AND MLL-REARRANGED ACUTE MYELOID LEUKEMIA

EHA Library, Hongxia Chen, 4160488

OXPHOS-DRIVEN M2-POLARIZED MACROPHAGES SUPPORT LEUKEMIC CELL GROWTH THROUGH MITOCHONDRIAL TRANSFER

EHA Library, Wendy Boschloo, 4160491

ONCOGENIC ASPP2K IN ACUTE MYELOID LEUKEMIA (AML): A POTENTIAL PREDICTIVE MARKER AND NOVEL THERAPEUTIC TARGET

EHA Library, Kerstin Kampa-Schittenhelm, 4160492

MANNOSE METABOLISM INHIBITION IS TOXIC TOWARDS ACUTE MYELOID LEUKAEMIA STEM CELLS WHILE SPARING NORMAL HAEMATOPOIETIC CELLS AT STEADY STATE.

EHA Library, Samantha Mason, 4160493

JAK2 R1063H GERMLINE VARIANT IN AML: ASSOCIATION WITH ONCOGENIC IDH1/2 DRIVERS RESULTING IN COOPERATIVE LEUKEMOGENESIS AND THERAPEUTIC IMPLICATIONS

EHA Library, Katarina Hlusickova Kapralova, 4160494

HIGH THROUGHPUT DRUG SCREEN COUPLED TO PROTEO-GENOMIC DATA IDENTIFIES EPIGENETIC VULNERABILITIES IN AML SUBTYPE-SPECIFIC PATIENT GROUP

EHA Library, Shanna Hogeling, 4160495

DECODING ACUTE MYELOID LEUKAEMIA: INTEGRATING FUNCTIONAL PHENOTYPES WITH GENOMICS

EHA Library, Prasad Iyer, 4160497

P16INK4A SUPPRESSION BY FLT3-ITD ENHANCES AML PROGRESSION: MECHANISTIC INSIGHTS AND THERAPEUTIC TARGETING OF EPIGENETIC REGULATORS

EHA Library, jiarui zheng, 4160498

IDENTIFICATION OF ELOVL6 AS A CAUSAL FACTOR AND POTENTIAL THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA

EHA Library, Linhui Hu, 4160499

RGT-61159, A POTENT AND SELECTIVE SMALL MOLECULE MYB RNA INHIBITOR, SHOWED SIGNIFICANT ANTI-TUMOR ACTIVITY AS MONOTHERAPY OR IN COMBINATION WITH STANDARDS OF CARE IN SEVERAL LEUKEMIA DISEASE MODELS HARBORING AML MOST COMMON GENETIC LESIONS

EHA Library, Patricia Soulard, 4160500

ACTIVIN A INHIBITION IMPAIRED IN VITRO AML CELL MIGRATION AND IN VIVO BONE MARROW ENGRAFTMENT IN MICE

EHA Library, Blake Moses, 4160503

DIRECT FUNCTIONAL HOXA9/DNA BINDING COMPETITORS VERSUS EPIGENETIC INHIBITORS OF HOXA9 EXPRESSION ON CELL PROLIFERATION, DEATH AND DIFFERENTIATION PROCESSES IN THE MODEL OF MLL-REARRANGED ACUTE MYELOID LEUKAEMIA

EHA Library, Marie-Helene David-Cordonnier, 4160504

COMPLEMENTARITY OF HIGH-THROUGHPUT SEQUENCING AND FLOW CYTOMETRY FOR MEASURABLE RESIDUAL DISEASE IN AML: A REAL LIFE STUDY FROM THE HAUTS-DE-FRANCE OBSERVATORY

EHA Library, Augustin Boudry, 4160505

THE TRANSCRIPTIONAL LANDSCAPE OF CLONAL AND MICROENVIRONMENT CELLS IN ACUTE MYELOID LEUKEMIA TREATED WITH HMA-VENETOCLAX AT SINGLE CELL LEVEL

EHA Library, Alfredo Marchetti, 4160506

HPK1 INHIBITOR BGB-15025 INDUCES APOPTOSIS IN AML CELLS THROUGH CELL CYCLE PATHWAY AND MAPK/ERK SIGNALING AXIS.

EHA Library, Shiyu Yang, 4160510

INTEGRATIVE SYSTEMS BIOLOGY APPROACH UTILIZING TRANSCRIPTOMIC AND MUTATIONAL PROFILES TO UNVEIL PROGNOSIS-ASSOCIATED MOLECULAR PATHWAYS IN ACUTE MYELOID LEUKEMIA

EHA Library, Xiaoxue Wang, 4160512

INTERLEUKIN-8 IMPEDES MEGAKARYOCYTES PROPLATELET FORMATION VIA CXCR1/2-P38-NF-E2 SIGNAL AXIS LEADING TO THROMBOCYTOPENIA IN ACUTE MYELOID LEUKEMIA

EHA Library, Jing-li Han, 4160513

DEEP TARGETED SEQUENCING TO MONITOR MEASURABLE RESIDUAL DISEASE AND CHIMERISM IN MIELOID MALIGANCIES AFTER ALLOGENIC STEM CELL TRANSPLANT

EHA Library, Irene Zamanillo, 4160514

AVPR2-DRIVEN NEUROHYPOPHYSEAL DYSFUNCTION IN ADVERSE-RISK CYTOGENETIC AML: MECHANISTIC INSIGHTS AND SURVIVAL IMPLICATIONS

EHA Library, Diyaer Abuduaini, 4160516

WHOLE GENOME SEQUENCING REVEALS MULTI-DIMENSIONAL GENETIC ABERRATIONS AND CONTRIBUTES SIGNIFICANTLY TO ELN 2022 RISK STRATIFICATION IN ACUTE MYELOID LEUKEMIA

EHA Library, Guangxin Peng, 4160517

RAB37 ORCHESTRATES THE SREBP/SCD AXIS TO MODULATE LIPID METABOLISM AND DRIVE FERROPTOSIS RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Jishi Wang, 4160518

(LEUKEMIA-SPECIFC) B-CELLS IN AML PATIENTS CAN BE INDUCED BY IMMUNE MODULATORY THERAPY (KIT M: GM-CSF AND PGE-1) AND CONTRIBUTE TO IMPROVE ANTILEUKEMIC RESPONSE

EHA Library, Helga Schmetzer, 4160520

TRANSCRIPTOMIC AND CELLULAR DECONVOLUTION ANALYSIS REVEALS DISTINCT PROFILES ASSOCIATED WITH CYTARABINE RESISTANCE IN ACUTE MYELOID LEUKEMIA

EHA Library, Alba Mora, 4160521

EXPLOITING TARGETED INHIBITION OF MASTL KINASE AS A NEW THERAPEUTIC TARGET FOR ACUTE MYELOID LEUKEMIA

EHA Library, Sandra M Martin-Guerrero, 4160522

RIPK3 INDUCES APOPTOSIS IN FLT3-MUTATED ACUTE MYELOID LEUKEMIA CELLS VIA REGULATION OF MFN2-MEDIATED MITOCHONDRIAL FUSION

EHA Library, yan zhang, 4160523

MOLECULAR CHARACTERISTICS OF AML DEFINED BY DIFFERENTIATION

EHA Library, Christoph Kornauth, 4160526

FROM XENOGRAFT TO PATIENT: THE IMPACT OF SURFACE MARKERS ON AML EXTRAMEDULLARY INVASION

EHA Library, Matteo Caridi, 4160527

VENETOCLAX INDUCES MITOCHONDRIAL APOPTOSIS AND AUTOPHAGY TO OVERCOME ARSENIC TRIOXIDE RESISTANCE IN ACUTE PROMYELOCYTIC LEUKEMIA

EHA Library, Syed Hasan, 4160528

PROGNOSTIC IMPACT OF FLT3-ITD LENGTH AND CLONAL PERSISTENCE IN MYELOID NEOPLASMS

EHA Library, Suresh Balasubramanian, 4160530

ANTI-LEUKEMIC ACTIVITY OF MITOTIC CHECKPOINT INHIBITOR BAL0891 AS MONOTHERAPY AND IN COMBINATION WITH TARGETED AGENTS

EHA Library, Mi Ji Choi, 4160531

CHARACTERISTICS AND PROGNOSTIC IMPACT OF IDH MUTATIONS IN A REAL-LIFE COHORT OF 217 PATIENTS WITH ACUTE MYELOID LEUKEMIA

EHA Library, Antonella Cucca, 4160532

THZ1-INDUCED DNA DAMAGE TRIGGERS BOTH P53-DEPENDENT AND INDEPENDENT APOPTOSIS IN AML

EHA Library, Weidong Ding, 4160534

HOW AML MIGHT EXPLOIT RNA GRANULES FOR STRESS SHELTER, MORE THAN OTHER CANCERS.

EHA Library, Alessandro Pilli, 4160535

ACUTE MYELOID LEUKEMIA WITH 7Q DELETION: INCIDENCE, PROGNOSTIC, AND IMPACT ON RESPONSE TO BORTEZOMIB IN COMBINATION WITH AZACITIDINE OF EZH2 ALTERATIONS.

EHA Library, Iván Martín, 4160536

EXPLORATION OF MUTATIONAL PATTERNS AND THEIR IMPACT ON THE IMMUNE MICROENVIRONMENT IN ACUTE MYELOID LEUKEMIA THROUGH IN SILICO ANALYSES

EHA Library, Allana Carvalho, 4160537

ABNORMAL DNA DAMAGE RESPONSE SUGGESTS NOVEL FINGERPRINT OF RELAPSE IN ACUTE MONOCYTIC LEUKEMIA POST TRANSPLANTATION

EHA Library, Yukun FENG, 4160538

A NEW ALGORITHM FOR HARMONIZING LARGE-SCALE RNA-SEQ INTEGRATION IN AML: ENABLING PLATFORM FOR DEEP ANALYSIS AND DISCOVERY

EHA Library, Matteo Caridi, 4160539

PAEONIFLORIN TARGETING M6A RNA METHYLATION IMPROVES BNIP3 ASSOCIATE MITOPHAGY IN DOXORUBICIN-INDUCED MYOCARDIAL CARDIOTOXICITY

EHA Library, Xing Cui, 4160541

LIMS1 REGULATES ACUTE MYELOID LEUKEMIA INITIATION THROUGH CELL-ADHESION INTERACTIONS AND MIGRATION OF LEUKEMIC STEM CELLS

EHA Library, Talia Velasco-Hernandez, 4160542

PATIENTS WITH RELAPSED OR REFRACTORY (R/R) NUCLEOPHOSMIN 1-MUTATED (NPM1M) ACUTE MYELOID LEUKEMIA (AML): UPDATED RESULTS FROM THE PHASE 2 AUGMENT-101 STUDY

EHA Library, Martha L Arellano, 4160543

VALIDATION OF THE EUROPEAN LEUKEMIANET 2024 RISK STRATIFICATION IN PATIENTS WITH NEWLY-DIAGNOSED AML TREATED WITH HMA+VEN: REAL-WORLD DATA BASED ON THE STUDY ALLIANCE LEUKEMIA AML REGISTRY

EHA Library, Lydia Kretschmer, 4160544

HYPOMETHYLANTS IN MONOTHERAPY OR COMBINED WITH VENETOCLAX: REAL-LIFE EXPERIENCE IN 1964 PATIENTS REPORTED TO THE PETHEMA-GPLA REGISTRY

EHA Library, Eliana Aguiar, 4160545

A PHASE IB/2 TRIAL OF AN ALL-ORAL „TRIPLET” REGIMEN FOR IDH-MUTATED MYELOID MALIGNANCIES: DECITABINE/CEDAZURIDINE AND VENETOCLAX IN COMBINATION WITH IVOSIDENIB/ENASIDENIB

EHA Library, Jennifer Marvin-Peek, 4160547

PROGNOSTIC VALUE OF MOLECULAR MEASURABLE RESIDUAL DISEASE MONITORED BY DIGITAL PCR BEFORE AND AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN TP53-MUTATED AML/MDS COHORT: A TROPHY STUDY

EHA Library, Yanmin Zhao, 4160548